Services

Professional and Cost-Saving Solutions

Structure-Based Mutagenesis & Combinatorial Enzyme Design

Creative Enzymes provides Structure-Based Mutagenesis and Combinatorial Enzyme Design Services that leverage advanced structural biology, computational modeling, and experimental mutagenesis to precisely reprogram enzyme functions. By integrating high-resolution structural data with combinatorial mutation strategies, we rationally identify and assemble beneficial mutations that enhance catalytic performance, stability, specificity, or tolerance under industrial conditions. Our platform merges molecular insight with combinatorial diversity, ensuring a rapid and efficient path from design concept to optimized enzyme variant. Whether for research, pharmaceutical synthesis, or industrial biocatalysis, Creative Enzymes delivers accurate, data-driven enzyme engineering solutions.

What Is Structure-Based Mutagenesis and Combinatorial Enzyme Design

Enzyme functionality is deeply rooted in its three-dimensional structure—each atom and residue contributes to the intricate choreography of catalysis. Understanding and exploiting this relationship form the foundation of structure-based enzyme design.

In contrast to random mutagenesis or purely empirical methods, structure-based mutagenesis allows targeted modification of amino acid residues guided by crystallographic or computational data. This approach ensures that each mutation is chosen with a clear purpose—whether stabilizing a flexible loop, optimizing substrate access, or reshaping the active site geometry for improved specificity.

To expand design possibilities beyond single mutations, combinatorial enzyme design explores the synergistic effects of multiple substitutions. By systematically combining individually beneficial mutations, it uncovers optimized variants with additive or even synergistic performance improvements. When integrated with computational predictions and high-throughput screening, this dual approach offers unprecedented control and efficiency in enzyme optimization.

Simplified workflow diagram of combinatorial enzyme designFigure 1. Combinatorial assembly and design of enzymes. (Lipsh-Sokolik et al., 2023)

Creative Enzymes combines rational mutagenesis, molecular modeling, and combinatorial assembly to deliver highly efficient enzyme design workflows. Our expertise spans diverse enzyme families, from hydrolases and oxidoreductases to transferases and lyases, serving applications across pharmaceuticals, green chemistry, food technology, and bioenergy industries.

Structure-Based Mutagenesis & Combinatorial Enzyme Design: What We Offer

Creative Enzymes provides a comprehensive suite of structure-guided mutagenesis and combinatorial design services that cover every stage of rational enzyme optimization:

Structural Analysis and Target Identification

  • Evaluation of crystal structures or homology models to identify catalytic residues, flexible regions, and stability-determining motifs.
  • Detection of mutational hotspots using computational scanning and residue interaction mapping.
  • Assessment of potential trade-offs between activity, stability, and substrate selectivity.

Structure-Based Mutagenesis

  • Rational design of single or multiple point mutations informed by structure–function relationships.
  • Mutations targeting hydrogen bonding, salt bridges, loop flexibility, hydrophobic packing, or cofactor binding.
  • Site-directed and saturation mutagenesis strategies to explore precise amino acid substitutions.

Combinatorial Enzyme Design

  • Systematic combination of beneficial single mutations using computational recombination algorithms.
  • Construction of combinatorial libraries that explore synergistic effects on enzyme performance.
  • Energy scoring and stability evaluation to identify optimal variant combinations prior to synthesis.

Computational Modeling and Simulation

  • Molecular docking and dynamics simulations to predict substrate interactions and conformational flexibility.
  • Calculation of energy landscapes, solvent effects, and residue stability scores.
  • Structural visualization and mutational impact prediction through in silico analyses.

Experimental Mutagenesis and Validation

  • High-accuracy site-directed mutagenesis and combinatorial library construction.
  • Expression and purification of selected variants.
  • Biochemical and kinetic assays for activity, stability, and enantioselectivity validation.

Integration with Downstream Applications

  • Transfer of optimized enzyme variants for industrial, pharmaceutical, or biosynthetic applications.
  • Optional downstream services including activity measurement, mechanistic study, and structural characterization.

Service Workflow

Service workflow for structure-based mutagenesis and combinatorial enzyme design

Project Outputs

Service Module Deliverables
Structural Analysis and Modeling 3D model, residue mapping, mutational hotspot report
Rational Mutagenesis Design Mutation proposal list, structural justification
Combinatorial Library Design Variant combinations, predicted energy scores
Molecular Dynamics & Docking Simulation Energy landscape, conformational analysis
Experimental Mutagenesis & Expression Verified mutant clones, purified enzyme
Enzymatic Characterization Kinetic data, stability profiles, activity comparison
Comprehensive Final Report Full analysis, experimental validation, future guidance

Inquiry

Our Distinguishing Advantages

Integrated Computational–Experimental Expertise

We combine computational enzyme design with experimental mutagenesis, ensuring a fully validated rational engineering process.

Precision Structural Insight

Our methods are rooted in structural biology and energy-based modeling, providing atomic-level understanding of enzyme function.

Efficient Combinatorial Strategy

Instead of screening thousands of random mutants, we intelligently design limited but high-probability combinations for maximal performance gains.

Cross-Disciplinary Team

Our team of biochemists, structural biologists, and computational scientists ensures that every design is biologically relevant and experimentally feasible.

Customizable and Scalable Solutions

From single-point improvements to large-scale combinatorial optimization, our services are tailored to each client's technical and industrial needs.

Quality Assurance and Confidentiality

Every project is conducted under strict quality control and protected by confidentiality agreements, ensuring both accuracy and data security.

Case Studies and Real-World Examples

Case 1: Highly Active Enzymes by Automated Combinatorial Backbone Assembly and Sequence Design

This study introduces an automated method for enzyme design using combinatorial backbone assembly, which creates new enzyme backbones from homologous yet diverse structures and optimizes them with Rosetta while preserving catalytic residues. Applied to two TIM-barrel enzyme families—GH10 xylanases and PLL lactonases—the approach generated 43 and 34 designs, respectively, with 21 GH10 and 7 PLL enzymes showing activity, including some from templates with <25% sequence identity. Four designs matched natural enzyme activity, and crystallography confirmed atomic-level accuracy. By strategically segmenting β-α backbone units and testing multiple segmentation schemes, the method demonstrated flexibility and potential for creating stable, active, and diverse enzymes.

Machine learning-guided co-optimization approach for designing diverse combinatorial enzyme librariesFigure 2. Different segmentation schemes used in combinatorial backbone assembly. a GH10(I): Each of eight β-α units were sampled independently, for maximal backbone diversity. b GH10(II): Segmenting β-α units 1, 2-4, 5–6, and 7–8 to preserve stabilizing interactions within each segment. c GH10(III): a discontinuous segmentation, in which the structurally conserved β-α units 1 and 5–6 formed one segment and two other segments were formed by units 2–4 and 7–8. d The homodimer interface in PLLs (β-α units 1–3 and 8, gray) was used as one backbone segment and units 4–7 were sampled independently. (Ding et al., 2024)

Case 2: Combinatorial Assembly and Design of Enzymes

This work presents CADENZ (Combinatorial Assembly and Design of ENZymes), a machine-learning and atomistic method that designs enzyme fragments capable of forming diverse, stable, and catalytically competent structures. Applied to endoxylanases, CADENZ produced thousands of active and structurally varied enzymes. Using Golden Gate Assembly, yeast display, and activity-based probes, researchers identified active designs, 58% of which catalyzed substrate conversion. Long-read sequencing revealed 3,114 distinct designs across 756 backbones—far exceeding natural diversity—with up to 169 mutations and 48–73% sequence identity to natural homologs. Incorporating insights on packing and preorganization improved success tenfold, yielding over 10,000 active enzymes.

CADENZ machine-learning and atomistic design platform generating diverse, active engineered enzymesFigure 3. CADENZ generates functional enzymes with high structure and sequence diversity. (A) (top) representative model structures of recovered enzymes designed by CADENZ. Regions that vary among the four designs are highlighted in colors. (bottom) active-site electrostatic potential surfaces of the representative designs exhibit marked differences (putative ligand-bound conformation marked in yellow sticks based on PDB entry 4PUD). (B) Distribution of sequence identity to nearest natural homologs of active backbones. (C) The number of unique structures from which fragments are sourced. Most active designs incorporate fragments from four different sources. (Lipsh-Sokolik et al., 2023)

Frequently Asked Questions

  • Q: What is the main difference between structure-based mutagenesis and random mutagenesis?

    A: Structure-based mutagenesis is a rational approach guided by enzyme 3D structures and computational analysis, focusing on specific residues critical for function. In contrast, random mutagenesis relies on stochastic mutations and screening without prior knowledge of structure or mechanism.
  • Q: What type of structural information is required to start a project?

    A: We can work with experimentally determined crystal structures, cryo-EM data, or computationally predicted models (such as AlphaFold2). If no structure is available, our team can perform homology modeling to generate one.
  • Q: Can you combine computational and experimental work in one project?

    A: Yes. Creative Enzymes offers an integrated workflow where computational modeling directly informs experimental mutagenesis, ensuring coherent design-to-validation execution.
  • Q: How large are the combinatorial libraries you typically generate?

    A: We design focused combinatorial libraries (ranging from dozens to hundreds of variants), ensuring efficient screening while maximizing the likelihood of identifying superior enzymes.
  • Q: What kinds of enzyme properties can be improved through this service?

    A: Our structure-based and combinatorial design approaches can enhance catalytic efficiency, substrate specificity, enantioselectivity, solvent tolerance, and thermostability, among others.
  • Q: How long does a typical project take?

    A: Depending on project complexity, a complete design–validation cycle usually takes 6–10 weeks, including computational analysis, mutagenesis, expression, and characterization.
  • Q: Do you offer downstream characterization of designed enzymes?

    A: Yes. We provide activity assays, kinetic parameter measurements, and structural validation to fully confirm the designed enzyme's improved performance.

References:

  1. Ding K, Chin M, Zhao Y, et al. Machine learning-guided co-optimization of fitness and diversity facilitates combinatorial library design in enzyme engineering. Nat Commun. 2024;15(1):6392. doi:10.1038/s41467-024-50698-y
  2. Lipsh-Sokolik R, Khersonsky O, Schröder SP, et al. Combinatorial assembly and design of enzymes. Science. 2023;379(6628):195-201. doi:10.1126/science.ade9434

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services
Online Inquiry

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.